Evaluating treatments for substance use problems in veterans
Impact of Combined Recovery Program and Home Telehealth Among Veterans With Substance Use Disorders in the VA Inpatient Setting
This study is testing three different treatment options for veterans with substance use problems to see which one helps them recover better after leaving the hospital.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 195 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (Charleston, South Carolina) |
| Trial ID | NCT05054738 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness of three treatment approaches for veterans with substance use disorders admitted to the Charleston VA Psychiatric inpatient unit. Participants will receive either the Combined Recovery Program (CRP), a six-session group therapy, a Home Telehealth program called Stable and Able (S&A) for support post-discharge, or Treatment-as-Usual (TAU). The study will follow participants for up to three months after discharge to evaluate outcomes related to recovery and quality of life. The goal is to reduce high rates of readmission and improve overall health and social functioning.
Who should consider this trial
Good fit: Ideal candidates are veterans diagnosed with substance use disorders who have used substances in the past 30 days and can engage in group therapy.
Not a fit: Patients with acute psychosis or significant auditory or visual impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved recovery outcomes and reduced readmission rates for veterans with substance use disorders.
How similar studies have performed: Previous studies have shown promise in using combined treatment approaches for substance use disorders, indicating potential for success in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Meeting DSM-V criteria for current SUD diagnosis of alcohol and/or illicit drug use disorder * Use of substances in past 30 days prior to date of index inpatient admission * Able to comprehend English * Able to provide informed consent * Functioning at an intellectual level sufficient to allow accurate completion of all assessments * Willing to commit to 6 group inpatient therapy sessions, telehealth S\&A, as well as baseline, and 1-and 3-month follow-up assessments Exclusion Criteria: * Auditory or visual impairment that would interfere with study procedures * Inability to speak or understand English * Acutely psychotic patients
Where this trial is running
Charleston, South Carolina
- Ralph H. Johnson VA Medical Center, Charleston, SC — Charleston, South Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Elizabeth J. Santa Ana, PhD MA BA — Ralph H. Johnson VA Medical Center, Charleston, SC
- Study coordinator: Elizabeth J Santa Ana, PhD MA BA
- Email: Elizabeth.SantaAna2@va.gov
- Phone: (843) 789-7168
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.